BT-256

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBT-256
Drug Alias NameBAC-alendronate (TSRL)BT-256
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionCalcium metabolism inhibitorsOsteoclasts inhibitorsBone resorption inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTherapeutic Systems Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherapeutic Systems Research Laboratories
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A